MDLN

Medline
D

MDLN

Arincen64/100B

Medline free cash flow 2022–2026

Medline's free cash flow in Q3 FY2026, the three months to 26 September 2026, was 884.00M USD, up 65.2% on the same quarter a year before. Medline's free cash flow in fiscal year 2025 was 1.30B USD, down 8.3% on the year before.

Last updated 9 Nov 2026 · Next report 24 Feb 2027

Free cash flow

Free cash flow Free cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM26 Sept 20261.90B—6.18%2.38B-486.00M1.99
FY202531 Dec 20251.30B-8.34%4.56%1.74B-447.00M1.60
FY202431 Dec 20241.42B+0.35%5.55%1.77B-354.00M1.80
FY202331 Dec 20231.41B—6.07%1.69B-275.00M1.79
FY202231 Dec 2022-67.00M—-0.31%187.00M-254.00M-0.09

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Cash flow

Common questions about Medline's free cash flow

Source: Financial Modeling Prep